about
The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent mannerLaminin isoform expression in breast tumors.Developments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitorsProteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesisAngiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice.Expression of angiostatin cDNA in human gallbladder carcinoma cell line GBC-SD and its effect on endothelial proliferation and growth.Glioma angiogenesis: Towards novel RNA therapeutics.Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetesThe endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model.Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells.NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells.Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.Basement membranes: cell scaffoldings and signaling platforms.DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumorsRapid vascular regrowth in tumors after reversal of VEGF inhibition.Vascular endothelial growth factor localization in the adult.Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retinaChanges in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factorAntitumor efficacy of a thrombospondin 1 mimetic CovX-bodyAngiogenesis and melanoma - from basic science to clinical trials.URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranesEndothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsyGinsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptorNMR solution structure of the angiostatic peptide anginex.Angiogenesis inhibitors in the treatment of cancer.Roles for VEGF in the adult.Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor.Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancerStructural basis for the functions of endogenous angiogenesis inhibitors.Gene therapy targeting to tumor endothelium.Preparation and characterization of a novel chimeric protein VEGI-CTT in Escherichia coli.Potential therapeutic strategies for lymphatic metastasis.
P2860
Q24302060-0749F61B-A5DA-45F2-815A-696CAE0761DCQ24810816-FCF10FC7-23A9-4CB3-8815-61828DD8662DQ27004391-FC156CFA-8DA1-4E5A-A2B7-0CFEDCFDBDDDQ28278230-2C5B1E94-A412-440B-AD13-ACE7AEDAC712Q33222336-EC044695-1785-4433-A609-B276343B0340Q33244333-DFFE915B-3A86-48EE-9E4D-C4577ACD5CC9Q33414996-60EAB81B-91A9-42D9-BC3A-91EDC729D124Q33591382-8ED052AA-CDF3-43CD-B736-935F7EFBDB6EQ33642146-AF01444A-E3D5-4666-A225-006F279CEA64Q33737146-9D49F4AE-6920-4E18-97DB-7E73319F6E0EQ33789026-FEC904EF-56B8-44F4-B7DC-45010DB6CDB5Q33896683-BF649E70-94D5-4AED-A8FE-A51D4E190700Q33990421-868CC168-F982-48AA-81E5-C9E3E219A047Q34033879-BFF916AD-F912-4A74-B067-9E957BDD573FQ34132787-7AE965A7-8E3E-4EDF-8E62-48A9BC3392F2Q34210916-39D1AC28-470E-434B-A379-3FDCC307E440Q34385843-99063BCD-8BD6-41C8-BC2B-84CBADE87428Q34576367-C3997B28-45D9-44A3-A3AD-760F43DAB666Q34701105-FBB42DFF-4263-4D7A-9977-1BC536293488Q35052385-01665FF5-C1E2-40E5-9B8E-EBA7413F0701Q35087955-4334A233-D5F1-4FB5-B255-56822B76FA3EQ35088245-7FA3842F-DA56-4796-99D9-4DD68D812A1AQ35091440-ED42DFF9-048F-428C-A01B-409587056D39Q35116833-D144EA42-CD28-4025-B948-C58A802F5586Q35380959-1ED79484-2CFC-4029-B51F-DF0AF665010FQ35623604-A41B40F7-BA38-4F81-8354-EDA26A54E81EQ35762984-5807F1F0-6CD2-4688-97ED-02C1C603DB86Q35849729-EA96B806-179E-4EA9-81FA-D32A0CC3EDA5Q35954001-F56188C8-6C25-4080-96CF-652225AA3962Q35960407-AE7C9B72-797D-4D8F-8939-6F02427AD2E3Q35995196-CDD6D5A0-6926-4708-86C2-D02CBA49BF00Q36003263-7F91EF28-2711-486A-BB1F-A169292FC313Q36222054-9E247186-6FC4-4715-AEA9-E574AC2B223EQ36248647-99979CE2-2B33-4303-A988-4F0330F73624Q36515948-AEED0026-4FF3-44EB-BF69-6D959A448915Q36540092-CD6879F8-25AB-4609-80B8-1799FF71B3D6Q36547755-3C68FE68-9E23-45DD-8D8A-842C51BAC5D2Q36649681-36D16FF5-45B9-467E-B28E-37CD2736BE4DQ36844365-27794574-73F2-49E9-8B05-5FA9E82835EBQ36851512-229E79B4-44FC-417B-A244-4987932D248A
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Endogenous angiogenesis inhibitors.
@ast
Endogenous angiogenesis inhibitors.
@en
Endogenous angiogenesis inhibitors.
@nl
type
label
Endogenous angiogenesis inhibitors.
@ast
Endogenous angiogenesis inhibitors.
@en
Endogenous angiogenesis inhibitors.
@nl
prefLabel
Endogenous angiogenesis inhibitors.
@ast
Endogenous angiogenesis inhibitors.
@en
Endogenous angiogenesis inhibitors.
@nl
P1476
Endogenous angiogenesis inhibitors.
@en
P2093
Judah Folkman
P304
P356
10.1111/J.1600-0463.2004.APM11207-0809.X
P577
2004-07-01T00:00:00Z